PARIS, France (AFP) - Two COVID-19 vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in two separate clinical trials, doctors said yesterday.The first trial among more than a thousand adults in Britain found that the vaccine induced 'strong antibody and T-cell immune responses' against the novel coronavirus.
